Brief: Codex DNA Signs Early Access Collaboration And Licensing Agreement With Pfizer

Telesis Bio

10/01/2022 11:50

Jan 10 (Reuters) - Codex DNA  DNAY.O 
    * CODEX DNA SIGNS EARLY ACCESS COLLABORATION AND LICENSING
AGREEMENT WITH PFIZER
    * CODEX DNA -  FINANCIAL TERMS OF DEAL INCLUDE UPFRONT
PAYMENT
FROM PFIZER, TECHNICAL MILESTONE PAYMENTS
    * CODEX DNA -  PFIZER’S SUCCESSFUL DEVELOPMENT &
COMMERCIALIZATION
OF LICENSED PRODUCTS COULD RESULT IN MILESTONE PAYMENTS IN
EXCESS OF $100 MILLION
    * CODEX DNA  - PFIZER, CO AGREE TO MULTI YEAR RESEARCH
COLLABORATION, LEVERAGING CO’S ENZYMATIC DNA SYNTHESIS (EDS)
TECHNOLOGY

Source text for Eikon:  urn:newsml:reuters.com:*:nGNX3kFzs9
Further company coverage:  DNAY.O 

 ((Reuters.Briefs@thomsonreuters.com;))